ライフサイエンスコーパス: androgen receptor antagonist

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 ed through structure-guided modifications of androgen receptor antagonists.

2 ovides strong rationale for developing novel androgen receptor antagonists.

3 ues were prepared and evaluated as potential androgen receptor antagonists against two human prostate

4 NP1 was absent with co-administration of the androgen receptor antagonist bicalutamide and in androge

5 Conversely, flutamide, an androgen receptor antagonist, did not affect androgen st

6 ed males and those receiving the competitive androgen receptor antagonist flutamide had significantly

7 fically, we bilaterally implanted the potent androgen receptor antagonist flutamide in two key brain

8 Finally, the androgen receptor antagonist flutamide inhibited the inc

9 were reversed by in vivo treatment with the androgen receptor antagonist flutamide, suggesting that

10 Moreover, prenatal administration of the androgen receptor antagonist, flutamide, equalizes devel

11 T4 in vivo and in vitro were reversed by the androgen receptor antagonist, flutamide, indicating that

12 caused by hCG treatment was prevented by the androgen receptor antagonist, flutamide.

13 F-0998425, (-)- 6a] is a novel, nonsteroidal androgen receptor antagonist for sebum control and treat

14 nowledge, DIM is the first example of a pure androgen receptor antagonist from plants.

15 Treatment with estrogen and androgen receptor antagonists had opposite effects on Le

16 ains androgen-receptor dependent, and potent androgen-receptor antagonists induce tumour regression i

17 ific antigen and objective responses with an androgen receptor antagonist (MDV3100).

18 at mediate a switch in function of selective androgen receptor antagonists/modulators (SARMs) from re

19 osterone was repressed by co-exposure to the androgen receptor antagonist nilutamide supporting a pot

20 A novel nonsteroidal androgen receptor antagonist, (R)-4-(1-benzyl-4,4-dimeth

21 Androgen receptor antagonists showed agonistic activity

22 MDV3100 is an androgen-receptor antagonist that blocks androgens from

23 Several new androgen receptor antagonists were synthesized and found

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。